NEW YORK, June 30, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) today announced that it is moving forward with manufacturing and process development work in preparation for clinical ...

Clene (NASDAQ: CLNN) announced key regulatory developments following a Type C meeting with the FDA, where it received feedback on its statistical an ...

A recent study involving researchers from the University of Basel reveals that slowing down the intracellular transport of ...

Researchers have developed a gene therapy that significantly slowed motor function loss in preclinical models of amyotrophic lateral sclerosis (ALS ...

A Nebraska-based biotech company is turning heads so far during Monday’s session after it announced that it is moving forward ...

According to a comprehensive market research report titled "Neurogenomics Market Size, Share, Forecast, & Trends Analysis by Offering ...

The Food and Drug Administration has granted Fast Track designation to AMX0114 for the treatment of amyotrophic lateral sclerosis (ALS).

In May 2024, physicians notified Keil that he had amyotrophic lateral sclerosis (ALS). ALS is a neurological illness that makes it difficult for a person to use their muscles over time. His friends ...

including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), today provided a regulatory update following a Type C meeting with the U.S. Food and Drug Administration (FDA), and announced ...

People who can no longer move or speak may soon have a new option: an implanted device that links their brain to a computer.

Matt Keil, the former bassist for Canadian band Comeback Kid, was diagnosed with Amyotrophic Lateral Sclerosis last month, with the condition already beginning to impact his day-to-day life. A ...